JenniferAnneWhitakerMD
Infectious Disease • Houston, TXAssistant Professor, Infectious Diseases, Mayo Medical School
Dr. Whitaker is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1504 Taub Loop
Houston, TX 77030Phone+1 713-873-4000Fax+1 507-255-3125
Education & Training
Emory UniversityMS, Clinical Research, 2010 - 2012
Emory University School of MedicineFellowship, Infectious Disease, 2009 - 2012- Emory University School of MedicineResidency, Internal Medicine, 2006 - 2009
Indiana University School of MedicineClass of 2006
Certifications & Licensure
TX State Medical License 2019 - 2026
MN State Medical License 2012 - 2019
GA State Medical License 2011 - 2013- American Board of Internal Medicine Infectious Disease
Publications & Presentations
PubMed
- 40 citationsAdversomics: a new paradigm for vaccine safety and designJennifer A. Whitaker, Inna G. Ovsyannikova, Gregory A. Poland
Expert Review of Vaccines. 2015-06-17 - 191 citationsMetabolic Phenotypes of Response to Vaccination in HumansShuzhao Li, Nicole L. Sullivan, Nadine Rouphael, Tianwei Yu, Sophia Banton
Cell. 2017-05-18 - 56 citationsComparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care WorkersElitza S. Theel, Heather Hilgart, Margaret K. Breen-Lyles, Kevin McCoy, Rhiannon Flury
Journal of Clinical Microbiology. 2018-06-25
Journal Articles
- Sharing the Spotlight in Durban: A Report from IAS TB2016 at AIDS2016Whitaker, JA, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases, 3/19/2017
Press Mentions
Tuesday, Jun 1 2021June 1st, 2021- Consent Laws Could Prevent Covid Vaccines for Some KidsJune 1st, 2021
- Second-Generation COVID-19 Vaccine Clinical Trial Starts at BCMMay 26th, 2021
- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
